AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 108 filers reported holding AVROBIO INC in Q4 2020. The put-call ratio across all filers is 2.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $18,000 | -35.7% | 3,172 | 0.0% | 0.00% | – |
| Q2 2021 | $28,000 | -30.0% | 3,172 | 0.0% | 0.00% | – |
| Q1 2021 | $40,000 | +100.0% | 3,172 | +122.4% | 0.00% | – |
| Q4 2020 | $20,000 | +5.3% | 1,426 | 0.0% | 0.00% | – |
| Q3 2020 | $19,000 | -24.0% | 1,426 | 0.0% | 0.00% | – |
| Q2 2020 | $25,000 | +13.6% | 1,426 | 0.0% | 0.00% | – |
| Q1 2020 | $22,000 | -21.4% | 1,426 | 0.0% | 0.00% | – |
| Q4 2019 | $28,000 | -17.6% | 1,426 | -32.5% | 0.00% | – |
| Q2 2019 | $34,000 | -26.1% | 2,113 | 0.0% | 0.00% | – |
| Q1 2019 | $46,000 | +35.3% | 2,113 | 0.0% | 0.00% | – |
| Q4 2018 | $34,000 | – | 2,113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
| Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
| MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
| GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
| Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
| Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
| XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
| Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |